| $350M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M | ||
| $100M |
Buys | $216,986,402 | 3 | 50 |
Sells | $4,920,820 | 3 | 50 |
| BAKER BROS. ADVISORS LP | 3 | $216.99M | 0 | $0 | $216.99M | |
| BORGESON JOHN A. | Chief Financial Officer | 0 | $0 | 3 | $4.92M | $-4.92M |
Kodiak Sciences Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering, advancing, and bringing to market treatments for various conditions affecting the retina. Their primary drug candidate, KSI-301, is an anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer. This compound is currently undergoing Phase IIb/III clinical trials, targeting illnesses such as wet age-related macular degeneration (AMD), diabetic macular edema, previously untreated macular edema resulting from retinal …
Over the last 12 months, insiders at Kodiak Sciences Inc. have bought $216.99M and sold $4.92M worth of Kodiak Sciences Inc. stock.
On average, over the past 5 years, insiders at Kodiak Sciences Inc. have bought $142.93M and sold $3.83M worth of stock each year.
Highest buying activity among insiders over the last 12 months: BAKER BROS. ADVISORS LP () — $216.99M.
The last purchase of 33,726 shares for transaction amount of $2.87M was made by BAKER BROS. ADVISORS LP () on 2026‑09‑29.
| 2026-10-21 | Sale | BORGESON JOHN A. | Chief Financial Officer | 30,000 0.049% | $90.01 | $2.7M | +10.62% | |
| 2026-09-29 | BAKER BROS. ADVISORS LP | 33,726 0.0503% | $85.05 | $2.87M | +2.03% | |||
| 2026-09-28 | BAKER BROS. ADVISORS LP | 1.91M 2.7367% | $80.77 | $154.12M | +3.04% | |||
| 2026-06-04 | Sale | BORGESON JOHN A. | Chief Financial Officer | 30,000 0.0566% | $34.10 | $1.02M | +17.95% | |
| 2026-04-02 | Sale | BORGESON JOHN A. | Chief Financial Officer | 30,000 0.0528% | $39.92 | $1.2M | +0.02% | |
| 2025-12-18 | BAKER BROS. ADVISORS LP | 2.61M 4.2971% | $23.00 | $60M | +40.33% | |||
| 2025-06-17 | Sale | BORGESON JOHN A. | See Remarks | 723 0.0014% | $3.65 | $2,640 | +541.41% | |
| 2024-06-17 | Sale | BORGESON JOHN A. | See Remarks | 2,874 0.0053% | $2.75 | $7,904 | +34.57% | |
| 2024-06-12 | Sale | BORGESON JOHN A. | See Remarks | 1,558 0.0031% | $2.92 | $4,549 | +28.67% | |
| 2023-06-16 | Sale | BORGESON JOHN A. | See Remarks | 2,749 0.0054% | $9.23 | $25,373 | -64.78% | |
| 2023-06-16 | Sale | EHRLICH JASON | See Remarks | 2,258 0.0044% | $9.23 | $20,841 | -64.78% | |
| 2023-06-14 | Sale | BORGESON JOHN A. | See Remarks | 1,448 0.0029% | $9.42 | $13,640 | -64.84% | |
| 2023-06-14 | Sale | EHRLICH JASON | See Remarks | 1,132 0.0023% | $9.42 | $10,663 | -64.84% | |
| 2022-06-15 | Sale | BORGESON JOHN A. | See Remarks | 2,798 0.0053% | $7.02 | $19,642 | +3.65% | |
| 2022-06-15 | Sale | EHRLICH JASON | See Remarks | 2,282 0.0043% | $7.02 | $16,020 | +3.65% | |
| 2022-06-02 | BAKER FELIX | 13,155 0.0255% | $7.93 | $104,363 | -6.75% | |||
| 2022-05-25 | BAKER FELIX | 116 0.0002% | $6.75 | $784 | +10.48% | |||
| 2022-05-16 | BAKER FELIX | 8,118 0.0163% | $5.99 | $48,599 | +29.47% | |||
| 2022-02-25 | Sale | PERLROTH VICTOR | Chairman and CEO | 340,000 0.6641% | $8.99 | $3.06M | -12.81% | |
| 2022-02-24 | Sale | PERLROTH VICTOR | Chairman and CEO | 1M 1.9233% | $9.20 | $9.2M | -16.03% |
| BAKER BROS. ADVISORS LP | 20191214 32.1263% | $2B | 44 | 0 | +11.65% | |
| BAKER FELIX | 15617369 24.8489% | $1.54B | 3 | 0 | +11.07% | |
| PROFUSEK ROBERT | director | 10000 0.0159% | $988,900.00 | 1 | 0 | <0.0001% |
| Levy Richard S | director | 1000 0.0016% | $98,890.00 | 1 | 0 | +41% |
$67,892,722 | 138 | 28.28% | $6.25B | |
$224,662,742 | 52 | 32.03% | $5.65B | |
Kodiak Sciences Inc. (KOD) | $613,304,943 | 46 | 11.85% | $6.22B |
$477,065,869 | 34 | 82.05% | $6B | |
$1,801,511 | 23 | 18.58% | $8.41B |
| Increased Positions | 100 | +81.97% | 17M | +39.37% |
| Decreased Positions | 53 | -43.44% | 4M | -10.02% |
| New Positions | 51 | New | 7M | New |
| Sold Out Positions | 13 | Sold Out | 1M | Sold Out |
| Total Postitions | 169 | +38.52% | 57M | +29.35% |
| Baker Bros. Advisors Lp | $450,419.00 | 28.85% | 17.31M | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $76,821.00 | 4.92% | 2.95M | -627,061 | -17.52% | 2025-09-30 |
| Point72 Asset Management, L.P. | $73,822.00 | 4.73% | 2.84M | +2M | +526.72% | 2025-09-30 |
| Vanguard Group Inc | $50,747.00 | 3.25% | 1.95M | +127,991 | +7.02% | 2025-09-30 |
| Adage Capital Partners Gp, L.L.C. | $34,737.00 | 2.23% | 1.33M | -720,707 | -35.06% | 2025-09-30 |
| Iconiq Capital, Llc | $32,956.00 | 2.11% | 1.27M | 0 | 0% | 2025-09-30 |
| Tcg Crossover Management, Llc | $29,807.00 | 1.91% | 1.15M | 0 | 0% | 2025-09-30 |
| Silverarc Capital Management, Llc | $26,020.00 | 1.67% | 1M | +598,460 | +149.04% | 2025-09-30 |
| Acadian Asset Management Llc | $25,237.00 | 1.62% | 969,906 | -999,970 | -50.76% | 2025-09-30 |
| State Street Corp | $21,660.00 | 1.39% | 832,443 | -4,778 | -0.57% | 2025-09-30 |